Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Add-on GLP-1 agonists for weight loss and/or business for 4-days of comprehensive, fun CME-accredited training like none other
AOD-9604 is available in a pre-mixed peptide solution which does not require peptide reconstitution
Most published work on BPC-157 involves cell culture systems, isolated tissue models, chick chorioallantoic membrane assays, or standardized rodent models
Improves Metabolic Function B12 supports the metabolism of carbohydrates, fats, and proteins, optimizing energy production and weight management
Following administration in animal models: BPC-157 demonstrates rapid systemic distribution within 15-30 minutes with unusual oral bioavailability TB-500 shows tissue-specific accumulation with preferential uptake in injured areas GHK-Cu exhibits copper-mediated transport and gene-modulating tissue binding KPV utilizes PepT1 transporter-mediated uptake with enhanced delivery to inflamed tissues Combined formulation provides immediate, sustained, and targeted bioactivity across multiple mechanisms Distribution studies suggest that injury sites and inflamed tissues tend to concentrate multiple components through different mechanisms BPC-157 through injury-site targeting, TB-500 through actin-rich repair zones, GHK-Cu through copper-dependent pathways, and KPV through upregulated PepT1 in inflammation, potentially enhancing local therapeutic effects
Regulatory Status: BPC-157 is not approved by major health authorities, which limits its legal use and accessibility
